Date: May 9, 2011
Title:
Notification of Completion of Exchange Act Filing Reviews
Date: Dec. 1, 2011
Title:
SEC Staff to Release Filing Review Correspondence Earlier
Date: April 5, 2012
Title:
Division announcement regarding confidential submission of draft registration statements under the Jumpstart Our Business Startups Act
Date: April 18, 2012
Title:
Republication of Commission Orders Revoking Exchange Act Registration and Stop Orders Under the Securities Act on EDGAR
Date: May 11, 2012
Title:
Division update regarding submission of draft registration statements for confidential review under the JOBS Act and non-public review under the Divisions policy for certain foreign private issuers
Date: June 28, 2012
Title:
Division update regarding the submission of draft registration statements submitted under the Jumpstart Our Business Startups Act and Division policy for certain foreign private issuers
Date: Sept. 26, 2012
Title:
Draft Registration Statements to Be Submitted and Filed on EDGAR
Date: Oct. 11, 2012
Title:
Draft Registration Statements Required to Be Submitted and Filed Using EDGAR Beginning October 15, 2012
Date: Dec. 19, 2012
Title:
Notice required by the Iran Threat Reduction and Syria Human Rights Act of 2012 to be filed through EDGAR
Date: Oct. 4, 2013
Title:
Acceleration of registration statements if there is a change in the SEC's operating status
Date: April 9, 2014
Title:
"Glossy" annual reports to security holders submitted to the SEC in paper will no longer be viewable on the SEC’s web site
Date: April 9, 2014
Title:
Division announces change to procedures relating to granted applications for confidential treatment
Date: Oct. 6, 2014
Title:
Draft Filing Review Program for Asset-Backed Securities Issuers
Announcement for Draft Filing Review Program for Asset-Backed Securities Issuers
Date: Jan. 16, 2015
Title:
Division of Corporation Finance Will Express No Views under Exchange Act Rule 14a-8(i)(9) for Current Proxy Season
Date: June 5, 2015
Title:
SEC Staff to Release Correspondence Relating to Securities Act Registration Statements That Are Not Reviewed
Announcement relating to the release of no-review letters on EDGAR
Date: Dec. 10, 2015
Title:
Recently Enacted Transportation Law Includes a Number of Changes to the Federal Securities Laws
Date: Dec. 18, 2015
Title:
Opportunity for Companies to Test File in Preparation for Crowdfunding Offerings
Date: April 29, 2016
Title:
Opportunity for Issuers to Receive Feedback on Test Filings in Preparation for Asset-Backed Securities Offerings That Require Asset-Level Data
Date: Oct. 5, 2016
Title:
"Tandy" Representations No Longer Needed in Filing Reviews
Date: Aug. 17, 2017
Title:
Draft Registration Statement Processing Procedures Expanded
Date: April 23, 2018
Title:
False Telephone Communications Claiming to Be from the SEC
Date: June 12, 2018
Title:
Division to Release through EDGAR Serious Deficiencies Letters
Date: Aug. 20, 2018
Title:
Division of Corporation Finance Staff to Continue to Enhance Transparency of Staff Actions
Date: April 1, 2019
Title:
New Rules and Procedures for Exhibits Containing Immaterial, Competitively Harmful Information
Date: Sept. 6, 2019
Title:
Announcement Regarding Rule 14a-8 No-Action Requests
Date: Sept. 26, 2019
Title:
Disclosure Program Realignment
Date: Dec. 19, 2019
Title:
CF Disclosure Guidance Topic: Intellectual Property and Technology Risks Associated with International Business Operations
Date: Dec. 19, 2019
Title:
CF Disclosure Guidance Topic: Confidential Treatment Applications Submitted Pursuant to Rules 406 and 24b-2
Date: March 10, 2020
Title:
Division of Corporation Finance Operating Status
Date: March 24, 2020
Title:
Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns
Date: March 25, 2020
Title:
CF Disclosure Guidance Topic: Coronavirus (COVID-19)
Date: April 7, 2020
Title:
Staff Guidance for Conducting Shareholder Meetings in Light of COVID-19 Concerns
Date: April 10, 2020
Title:
Division of Corporation Finance Statement Regarding Requirements for Form 144 Paper Filings in Light of COVID-19 Concerns
Date: April 23, 2020
Title:
Division of Corporation Finance Statement Regarding Requirements for Certain Paper Documents (other than Forms 144) in Light of COVID-19 Concerns
Date: June 23, 2020
Title:
CF Disclosure Guidance Topic: COVID-19 Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources
Date: June 25, 2020
Title:
Division of Corporation Finance Statement Regarding Requirements for Certain Paper Documents (other than Forms 144) in Light of COVID-19 Concerns
Date: June 25, 2020
Title:
Division of Corporation Finance Statement Regarding Requirements for Form 144 Paper Filings in Light of COVID-19 Concerns
Date: June 25, 2020
Title:
Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns
Date: Aug. 4, 2020
Title:
Division of Corporation Finance Statement Regarding Submission of Supplemental Materials and Information Subject to Rule 83 Confidential Treatment Requests in Light of COVID-19 Concerns
Date: Sept. 9, 2020
Title:
CF Disclosure Guidance Topic No. 7 updated to provide new guidance relating to options available to companies whose confidential treatment orders are about to expire.
Date: Nov. 20, 2020
Title:
Staff Statement Regarding Rule 302(b) of Regulation S-T in Light of COVID-19 Concerns
Date: Nov. 23, 2020
Title:
CF Disclosure Guidance Topic: Disclosure Considerations for China-Based Issuers
Date: Dec. 22, 2020
Title:
CF Disclosure Guidance Topic: Special Purpose Acquisition Companies